Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-17

Clinical Trial Update: Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combination chemotherapy with or without irinotecan for stage III colon cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combination chemotherapy
  • Irinotecan (Irinotecan)

Snippet

Sponsor: UNICANCER | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED